Matches in Wikidata for { <http://www.wikidata.org/entity/Q96684636> ?p ?o ?g. }
Showing items 1 to 44 of
44
with 100 items per page.
- Q96684636 description "artículu científicu espublizáu en xunu de 2020" @default.
- Q96684636 description "scientific article published on 25 June 2020" @default.
- Q96684636 description "wetenschappelijk artikel" @default.
- Q96684636 description "наукова стаття, опублікована 25 червня 2020" @default.
- Q96684636 description "գիտական հոդված հրատարակված 2020 թվականի հունիսի 25-ին" @default.
- Q96684636 name "APEX: a phase II randomised clinical trial evaluating the safety and preliminary efficacy of oral X-82 to treat exudative age-related macular degeneration" @default.
- Q96684636 name "APEX: a phase II randomised clinical trial evaluating the safety and preliminary efficacy of oral X-82 to treat exudative age-related macular degeneration" @default.
- Q96684636 type Item @default.
- Q96684636 label "APEX: a phase II randomised clinical trial evaluating the safety and preliminary efficacy of oral X-82 to treat exudative age-related macular degeneration" @default.
- Q96684636 label "APEX: a phase II randomised clinical trial evaluating the safety and preliminary efficacy of oral X-82 to treat exudative age-related macular degeneration" @default.
- Q96684636 prefLabel "APEX: a phase II randomised clinical trial evaluating the safety and preliminary efficacy of oral X-82 to treat exudative age-related macular degeneration" @default.
- Q96684636 prefLabel "APEX: a phase II randomised clinical trial evaluating the safety and preliminary efficacy of oral X-82 to treat exudative age-related macular degeneration" @default.
- Q96684636 P1433 Q96684636-09FEE1AF-C559-46FF-9420-FEF78E7D2290 @default.
- Q96684636 P1476 Q96684636-1E25E25B-A711-4E2B-AF7B-2D6EB37D72E6 @default.
- Q96684636 P2093 Q96684636-2D425F3F-7090-4FE8-96EB-DA8AA3F5E41F @default.
- Q96684636 P2093 Q96684636-7DF6A70D-CE2A-4B0A-A9BB-47754E0D9A37 @default.
- Q96684636 P2093 Q96684636-8551D532-F48B-4C65-9882-BD79D6FE7689 @default.
- Q96684636 P2093 Q96684636-868BE8BF-8C01-4EE7-AA7D-41CD6605F23E @default.
- Q96684636 P2093 Q96684636-B4E79D5E-3043-426C-B43E-5D670799B4B7 @default.
- Q96684636 P2093 Q96684636-C0BD0E53-57AA-49C8-B2A1-E92C38D905C4 @default.
- Q96684636 P2093 Q96684636-ED2B75CB-5C9A-49CF-8C37-039E219413A2 @default.
- Q96684636 P31 Q96684636-437FC724-7F14-4CE3-B66F-B6A0D1695C42 @default.
- Q96684636 P356 Q96684636-567126AF-F3F0-4806-BDED-D44353CE6871 @default.
- Q96684636 P50 Q96684636-0A25AA22-915C-463F-8844-2F7B67BBEEB9 @default.
- Q96684636 P577 Q96684636-F34232A1-4ADD-4920-9380-3E639CAE3B16 @default.
- Q96684636 P698 Q96684636-6E7F5E3A-1EB5-4056-950C-79007AE07D95 @default.
- Q96684636 P921 Q96684636-8A946FED-D10B-48A4-A749-B3AF1989ED64 @default.
- Q96684636 P356 BJOPHTHALMOL-2020-316511 @default.
- Q96684636 P698 32586932 @default.
- Q96684636 P1433 Q13443571 @default.
- Q96684636 P1476 "APEX: a phase II randomised clinical trial evaluating the safety and preliminary efficacy of oral X-82 to treat exudative age-related macular degeneration" @default.
- Q96684636 P2093 "Carl C Awh" @default.
- Q96684636 P2093 "Daniel E Salazar" @default.
- Q96684636 P2093 "Denis O'Shaughnessy" @default.
- Q96684636 P2093 "Jeffrey S Heier" @default.
- Q96684636 P2093 "Jennifer Cerami" @default.
- Q96684636 P2093 "Kate Fisher" @default.
- Q96684636 P2093 "Philip Rosenfeld" @default.
- Q96684636 P31 Q13442814 @default.
- Q96684636 P356 "10.1136/BJOPHTHALMOL-2020-316511" @default.
- Q96684636 P50 Q96684634 @default.
- Q96684636 P577 "2020-06-25T00:00:00Z" @default.
- Q96684636 P698 "32586932" @default.
- Q96684636 P921 Q42824440 @default.